Guillaume Pousaz, chief of a transaction-processing startup with a soaring valuation, says the future of banking will be built on payments companies
The newest face of the payments frenzy that has investors cheering and bank bosses scrambling is a 37-year-old Swiss surfer who dropped out of college to ride waves up and down the California coast.
Guillaume Pousaz spent roughly a decade transforming a low-tech payments firm he acquired into Checkout.com, a London-based transaction processor for fast-growing internet companies. Fresh off a nine-figure fundraising, the company is beefing up its presence in the U.S. and getting into other financial services, such as issuing...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Monsanto faces thousands of Roundup-cancer lawsuits after $2 billion verdict“We’re not suing them for the fact that their product causes cancer. We’re suing them because they didn’t tell people that it causes cancer.”
Read more »
TransferWise is now Europe's most valuable fintech start-up, with a $3.5 billion valuationTransferWise, the money transfer start-up, was valued at $3.5 billion after investors bought $292 million of shares in a secondary sale.
Read more »
Nascar to buy International Speedway in deal valued at $2 billion, at a 7% premium to original per-share bidInternational Speedway Corp. announced Wednesday a deal to be acquired by Nascar Holdings Inc. in a deal valued at $2.0 billion. Under terms of the deal,...
Read more »
Geoffrey Rush awarded $2 million in Sydney defamation caseOscar-winning actor Geoffrey Rush awarded $2 million in defamation case over reports he had been accused of inappropriate behavior toward an actress.
Read more »
RNC paid $2 million to law firm employing former White House counsel Donald McGahnThe RNC said the payment encompassed two years of work by the law firm Jones Day on a variety of matters.
Read more »
This $2 app changed the way I work.NBCNewsBETTER: With the Pomodoro Technique, you pick a task, set a timer for 25 minutes to work on that one thing, take a 5-minute break when the timer rings and repeat.
Read more »
Gene therapy gets FDA approval -- and a $2 million price tagThe FDA approved a treatment for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2. The price tag? $2.125 million for a one-time treatment.
Read more »
U.S. approves $2 million Novartis gene therapy for rare, deadly muscle disorderZURICH/NEW YORK - Swiss drugmaker Novartis won U.S. approval for its gene therap...
Read more »
Novartis $2 million gene therapy for rare disorder is world's most expensive drugSwiss drugmaker Novartis won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA) and priced the one-time treatment at a record $2.125 million
Read more »